Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Inzelberg

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Neuroepidemiology|January 1, 1994
Natural course of idiopathic torsion dystonia among JewsN Zilber, R Inzelberg, E Kahana, et al.
Clinical Neuropharmacology|January 12, 2001
A comparison of dopamine agonists and catechol-O-methyltransferase inhibitors in Parkinson's diseaseR Inzelberg, R L Carasso, E Schechtman, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 1, 1995
Kinematic properties of upper limb trajectories in idiopathic torsion dystoniaR Inzelberg, T Flash, E Schechtman, et al.
Annals of Neurology|August 26, 1998
Apolipoprotein E and Parkinson's diseaseR Inzelberg, D Paleacu, J Chapman, et al.
Functional Neurology|October 1, 1991
Juvenile segmental muscular atrophyM Y Neufeld, R Inzelberg, P Nisipeanu, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 1, 1995
Long-term tolerability and efficacy of cabergoline, a new long-acting dopamine agonist, in Parkinson's diseaseR Inzelberg, P Nisipeanu, M J Rabey, et al.
Clinical Neuropharmacology|June 1, 1994
Beneficial effect of cabergoline, new long-lasting D2 agonist in the treatment of Parkinson's diseaseJ M Rabey, P Nissipeanu, R Inzelberg, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 12, 2000
Alien hand sign in Creutzfeldt-Jakob diseaseR Inzelberg, P Nisipeanu, S C Blumen, et al.
Neuroepidemiology|January 1, 1994
Basal ganglia lacunes and parkinsonismR Inzelberg, N M Bornstein, I Reider, et al.
Statistics in Medicine|November 20, 1998
A statistical method for quantitative evaluation of the progression of chronic diseases: the mean score graph (MSG)N Zilber, O Manor, R Inzelberg, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Neuroepidemiology|January 1, 1994
Natural course of idiopathic torsion dystonia among JewsN Zilber, R Inzelberg, E Kahana, et al.
Clinical Neuropharmacology|January 12, 2001
A comparison of dopamine agonists and catechol-O-methyltransferase inhibitors in Parkinson's diseaseR Inzelberg, R L Carasso, E Schechtman, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 1, 1995
Kinematic properties of upper limb trajectories in idiopathic torsion dystoniaR Inzelberg, T Flash, E Schechtman, et al.
Annals of Neurology|August 26, 1998
Apolipoprotein E and Parkinson's diseaseR Inzelberg, D Paleacu, J Chapman, et al.
Functional Neurology|October 1, 1991
Juvenile segmental muscular atrophyM Y Neufeld, R Inzelberg, P Nisipeanu, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 1, 1995
Long-term tolerability and efficacy of cabergoline, a new long-acting dopamine agonist, in Parkinson's diseaseR Inzelberg, P Nisipeanu, M J Rabey, et al.
Clinical Neuropharmacology|June 1, 1994
Beneficial effect of cabergoline, new long-lasting D2 agonist in the treatment of Parkinson's diseaseJ M Rabey, P Nissipeanu, R Inzelberg, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 12, 2000
Alien hand sign in Creutzfeldt-Jakob diseaseR Inzelberg, P Nisipeanu, S C Blumen, et al.
Neuroepidemiology|January 1, 1994
Basal ganglia lacunes and parkinsonismR Inzelberg, N M Bornstein, I Reider, et al.
Statistics in Medicine|November 20, 1998
A statistical method for quantitative evaluation of the progression of chronic diseases: the mean score graph (MSG)N Zilber, O Manor, R Inzelberg, et al.
Pageof 6